EMEA-002343-PIP01-18
Key facts
Active substance |
|
Therapeutic area |
Infectious diseases
|
Decision number |
P/0231/2019
|
PIP number |
EMEA-002343-PIP01-18
|
Condition(s) / indication(s) |
Prevention of infectious diseases caused by Corynebacterium diphtheriae, Clostridium tetani and Bordetella pertussis
|
Route(s) of administration |
Intramuscular use
|
Contact for public enquiries |
Vakzine Projekt Management GmbH
Tel.+4951116990819 |
Decision type |
RP: decision refers to a refusal on a proposed Paediatric Investigation Plan
|